183 related articles for article (PubMed ID: 5525622)
1. [Immunoglobulins in the serum, sputum and saliva in patients affected with cystic fibrosis (mucoviscidosis) and important respiratory complications].
Marcer V; Mastella G; Mengoli V
Riv Clin Pediatr; 1970; 83(3):135-43. PubMed ID: 5525622
[No Abstract] [Full Text] [Related]
2. Some immunologic considerations of chronic pulmonary infection in cystic fibrosis.
Gifford RR
J S C Med Assoc; 1972 May; 68(5):204-7. PubMed ID: 4554120
[No Abstract] [Full Text] [Related]
3. Local humoral immunity and immune reactions in the lungs of patients with cystic fibrosis.
Schiøtz PO
Acta Pathol Microbiol Scand Suppl; 1981; 276():1-25. PubMed ID: 6951389
[No Abstract] [Full Text] [Related]
4. [Local immunity in children with mucoviscidosis].
Michailowa SM; Ratschinskij SW; Michejewa GA
Kinderarztl Prax; 1985 Jun; 53(6):297-300. PubMed ID: 4046333
[No Abstract] [Full Text] [Related]
5. [Bacteriologic surveillance of the sputum of 22 patients with mucoviscidosis].
Feigelson J; Pecau Y
Arch Fr Pediatr; 1967 Dec; 24(10):1135-47. PubMed ID: 5590823
[No Abstract] [Full Text] [Related]
6. Pseudomonas aeruginosa infection in cystic fibrosis. Distribution of B and T lymphocytes in relation to the humoral immune response.
Hoiby N; Mathiesen L
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):559-66. PubMed ID: 4213329
[No Abstract] [Full Text] [Related]
7. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
[TBL] [Abstract][Full Text] [Related]
8. [Proteins of bronchial secretions in mucoviscidosis. Role of infection].
Jacquot J; Tournier JM; Carmona TG; Puchelle E; Chazalette JP; Sadoul P
Bull Eur Physiopathol Respir; 1983; 19(5):453-8. PubMed ID: 6605774
[TBL] [Abstract][Full Text] [Related]
9. [Serum levels of immunoglobulins A, D, G and M and IgA in the saliva of children with recurrent infections of the respiratory tract].
Jankowski A; Kowalik W; Ziemiańska E; Schneidery W
Pol Tyg Lek; 1987 Jul; 42(29):881-3. PubMed ID: 3684768
[No Abstract] [Full Text] [Related]
10. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
[TBL] [Abstract][Full Text] [Related]
11. Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation.
Bonvillain RW; Valentine VG; Lombard G; LaPlace S; Dhillon G; Wang G
J Heart Lung Transplant; 2007 Sep; 26(9):890-7. PubMed ID: 17845927
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary infections in cystic fibrosis.
Acta Paediatr Scand Suppl; 1982; 301():1-132. PubMed ID: 6963850
[No Abstract] [Full Text] [Related]
13. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.
Bauernfeind A; Przyklenk B
Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748
[No Abstract] [Full Text] [Related]
14. Bacterial flora of respiratory tract in patients with cystic fibrosis, 1950-71.
Mearns MB; Hunt GH; Rushworth R
Arch Dis Child; 1972 Dec; 47(256):902-7. PubMed ID: 4630477
[TBL] [Abstract][Full Text] [Related]
15. Azlocillin in cystic fibrosis.
Malmborg AS; Alfredsson H; Strandvik B
Isr J Med Sci; 1983 Nov; 19(11):1001-3. PubMed ID: 6662681
[TBL] [Abstract][Full Text] [Related]
16. Bacterial infection in cystic fibrosis.
May JR; Herrick NC; Thompson D
Arch Dis Child; 1972 Dec; 47(256):908-13. PubMed ID: 4630478
[TBL] [Abstract][Full Text] [Related]
17. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
[TBL] [Abstract][Full Text] [Related]
18. The local immune status in cystic fibrosis.
Pryjma J; Rudnik J; Zebrak J; Herman T; Gaweł J
Monogr Paediatr; 1979; 10():125-30. PubMed ID: 460268
[No Abstract] [Full Text] [Related]
19. [The level of homologous antibodies against Proteus and Pseudomonas in patients treated in a respiratory diseases department. I. 4 variants of the mutual reaction between the bacterium and the human body].
Bognár S; Petrás G; Lányi B
Orv Hetil; 1973 Sep; 114(39):2345-51. PubMed ID: 4748046
[No Abstract] [Full Text] [Related]
20. Essential fatty acid deficiency in the rabbit as a model of nutritional impairment in cystic fibrosis. In vitro and in vivo effects on lung defense mechanisms.
Harper TB; Chase HP; Henson J; Henson PM
Am Rev Respir Dis; 1982 Sep; 126(3):540-7. PubMed ID: 7125341
[No Abstract] [Full Text] [Related]
[Next] [New Search]
